Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
AUTHORS
Pettit
AC ,
Jenkins
CA ,
Stinnette
SE ,
Rebeiro
PF ,
Blackwell
RB ,
Raffanti
SP ,
Shepherd
BE ,
Sterling
TR ,
. Journal of acquired immune deficiency syndromes (1999). 2011 8 1; 57(4). 305-10
- PMID: 21423024 [PubMed].
- PMCID: PMC3141096.
- NIHMSID: NIHMS285670
ABSTRACT
To evaluate the short-term and long-term effects of highly active antiretroviral therapy (HAART) on tuberculosis (TB) risk compared with risk without HAART in a low TB incidence setting.
To evaluate the short-term and long-term effects of highly active antiretroviral therapy (HAART) on tuberculosis (TB) risk compared with risk without HAART in a low TB incidence setting.
Tags: Published Thesis Products 2011